Teva Investigational Site 1264 — Amherst, New York

Teva Investigational Site 1264 is a clinical research site located in Amherst, New York, United States 14226.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 1264 has participated in 2 clinical trials.

Therapeutic areas: Relapsing Multiple Sclerosis, Multiple Sclerosis.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Amherst

Browse all research sites in New York · View every site in Amherst

• University at Buffalo
• University of Buffalo
• Dent Neurologic Institute
• Dent Neurosciences Research Center
• Dent Neurological Institute
• Research Site
• Dent Neurologic Institute Amherst
• GSK Investigational Site
• Pfizer Investigational Site
• Center for Children and Families
• Teva Investigational Site 13576
• Clinical Trial Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 1264?

Teva Investigational Site 1264 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 1264 conducted?

Teva Investigational Site 1264 has 2 clinical trials on record. Their work covers Relapsing Multiple Sclerosis, Multiple Sclerosis.

Is Teva Investigational Site 1264 accredited by Crixeo Clinical Trials?

Teva Investigational Site 1264 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 1264?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.